Back to Browse Journals » Open Access Rheumatology: Research and Reviews » Volume 4

Tocilizumab in the treatment of systemic juvenile idiopathic arthritis

Authors Murakami M, Tomiita M, Nishimoto N

Received 11 February 2012

Accepted for publication 21 March 2012

Published 5 July 2012 Volume 2012:4 Pages 71—79


Review by Single-blind

Peer reviewer comments 4

Miho Murakami,1 Minako Tomiita,2,3 Norihiro Nishimoto1
1Laboratory of Immune Regulation, Wakayama Medical University, Wakayama, 2Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, 3Department of Allergy and Rheumatology, Chiba Children's Hospital, Chiba, Japan

Abstract: Systemic juvenile idiopathic arthritis is one of the common rheumatic diseases in childhood and characterized by spiking fever, evanescent skin rash, lymphadenopathy, hepatosplenomegaly, and serositis, in addition to arthritis. Children with systemic juvenile idiopathic arthritis often show growth retardation and developmental abnormality, as well as macrophage activation syndrome, a life-threatening complication. Overproduction of interleukin-6 is pathologically responsible for the systemic inflammatory manifestations and abnormal laboratory results with systemic juvenile idiopathic arthritis. Thus, tocilizumab, a humanized antihuman interleukin-6 receptor antibody, has been developed as a therapeutic agent for the disease. A series of clinical studies have demonstrated the excellent efficacy and safety of tocilizumab for patients with active disease. Tocilizumab was approved for systemic juvenile idiopathic arthritis in Japan in 2008 and in the European Union and the United States in 2011.

Keywords: systemic juvenile idiopathic arthritis, tocilizumab, antihuman interleukin-6 receptor antibody, biologics

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Panobinostat for the treatment of multiple myeloma: the evidence to date

Bailey H, Stenehjem DD, Sharma S

Journal of Blood Medicine 2015, 6:269-276

Published Date: 8 October 2015

Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma

Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Hogan WJ, Markovic SN

Journal of Blood Medicine 2015, 6:45-53

Published Date: 2 February 2015

Responses of advanced directives by Jehovah's Witnesses on a gynecologic oncology service

Nagarsheth NP, Gupta N, Gupta A, Moshier E, Gretz H, Shander A

Journal of Blood Medicine 2015, 6:17-23

Published Date: 24 December 2014

A new recombinant factor VIII: from genetics to clinical use

Santagostino E

Drug Design, Development and Therapy 2014, 8:2507-2515

Published Date: 12 December 2014

The diagnosis and treatment of dyskeratosis congenita: a review

Fernández García MS, Teruya-Feldstein J

Journal of Blood Medicine 2014, 5:157-167

Published Date: 21 August 2014

Efficacy of intensity-modulated radiotherapy combined with chemotherapy or surgery in locally advanced squamous cell carcinoma of the head-and-neck

Yang H, Diao LQ, Shi M, Ma R, Wang JH, Li JP, Xiao F, Xue Y, Xu M, Zhou B

Biologics: Targets and Therapy 2013, 7:223-229

Published Date: 18 October 2013

Treatment of patients with von Willebrand disease [Erratum]

Tuohy E, Litt E, Alikhan R

Journal of Blood Medicine 2013, 4:57-58

Published Date: 20 May 2013

Corrigendum: Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision

Espandar L, Sikder S, Moshirfar M

Clinical Ophthalmology 2011, 5:159-160

Published Date: 6 February 2011

Solitary plasmacytoma of the jaw

Serena Marotta, Pierpaolo Di Micco

Journal of Blood Medicine 2010, 1:33-36

Published Date: 30 March 2010